# Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma

> **NCT01882231** · NA · TERMINATED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- Osteosarcoma
- Paget's Disease
- Ewing Sarcoma

## Interventions

- **OTHER:** DCE-MRI, DW-MRI, MT-MRI, and CEST-MRI

## Key facts

- **NCT ID:** NCT01882231
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03
- **Primary completion:** 2016-04-25
- **Final completion:** 2016-04-25
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Slow accrual and lack of funding
- **Last updated:** 2017-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01882231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01882231, "Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01882231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*